FIELD: medicine, cardiology in particular.
SUBSTANCE: invention relates to medicine, namely to cardiology. The level of beta-adrenoreactivity of erythrocyte membranes in the blood is determined in patients. Then, the prognostic risk factor for ventricular tachycardia is calculated according to the original formula. The formula is calculated using the indicator of the level of beta-adrenoreactivity of red blood cell membranes in the blood. If the prognostic coefficient based on the results of determining the level of beta-adrenoreactivity of erythrocyte membranes in the blood is 0.304 or more, then the patient is predicted to have a high risk of ventricular tachycardia.
EFFECT: method makes it possible to increase the effectiveness of antiarrhythmic therapy in patients with a high risk of ventricular tachycardia, thereby improving the quality of life of patients.
1 cl, 1 dwg, 2 tbl, 6 ex
